Influence of Different Promoters on the Expression Pattern of Mutated Human α-Synuclein in Transgenic Mice

No abstract is available for this paper.

• Publication year

  2005

• Venue

  Neurodegenerative Diseases

• Publication date

  2005-05-01

• Fields of study

  Biology, Medicine

• Identifiers
  DOI 10.1159/000085064PMID 16908976
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Neuronal !-Synucleinopathy with Severe Movement Disorder in Mice Expressing A 53 T Human !-Synuclein

  2007cited by this paper
• The priori protein gene: a role in mouse embryogenesis?

  2005cited by this paper
• Risk factors for dopaminergic neuron loss in human α‐synuclein transgenic mice

  2004cited by this paper
• The new mutation, E46K, of α‐synuclein causes parkinson and Lewy body dementia

  2004cited by this paper
• Risk factors for dopaminergic neuron loss in human alpha-synuclein transgenic mice.

  2004cited by this paper
• Ultrastructure of PkC(II/III)-immunopositive structures in rat primary visual cortex

  2004cited by this paper
• Transgenic mice expressing mutant A53T human alpha-synuclein show neuronal dysfunction in the absence of aggregate formation.

  2003influential reference
• Motor dysfunction and gliosis with preserved dopaminergic markers in human alpha-synuclein A30P transgenic mice.

  2003cited by this paper
• alpha-Synuclein locus triplication causes Parkinson's disease.

  2003cited by this paper
• α-Synuclein Locus Triplication Causes Parkinson's Disease

  2003cited by this paper
• The mouse brain in stereotaxic coordinates

  2003cited by this paper
• Transgenic and knockout models for studying the role of lung antioxidant enzymes in defense against hyperoxia.

  2002cited by this paper
• Behavioral and neurochemical effects of wild-type and mutated human alpha-synuclein in transgenic mice.

  2002cited by this paper
• Human alpha-synuclein-harboring familial Parkinson's disease-linked Ala-53 --> Thr mutation causes neurodegenerative disease with alpha-synuclein aggregation in transgenic mice.

  2002cited by this paper
• Selective expression of prion protein in peripheral tissues of the adult mouse.

  2002cited by this paper
• Human α-synuclein-harboring familial Parkinson's disease-linked Ala-53 → Thr mutation causes neurodegenerative disease with α-synuclein aggregation in transgenic mice

  2002cited by this paper
• Neuronal alpha-synucleinopathy with severe movement disorder in mice expressing A53T human alpha-synuclein.

  2002cited by this paper
• Differential neuropathological alterations in transgenic mice expressing α‐synuclein from the platelet‐derived growth factor and Thy‐1 promoters

  2002cited by this paper
• The synucleins

  2001cited by this paper
• Sensitivity to MPTP is not increased in Parkinson's disease‐associated mutant α‐synuclein transgenic mice

  2001cited by this paper
• Differential expression of cellular prion protein in mouse brain as detected with multiple anti-PrP monoclonal antibodies.

  2001cited by this paper
• Lack of Nigral Pathology in Transgenic Mice Expressing Human α-Synuclein Driven by the Tyrosine Hydroxylase Promoter

  2001cited by this paper
• Expression of SAG-1 of Toxoplasma gondii in transgenic mice

  2000cited by this paper
• Strong, long-term transgene expression in rat liver using chicken beta-actin promoter associated with cytomegalovirus immediate-early enhancer (CAG promoter).

  2000cited by this paper
• Subcellular Localization of Wild-Type and Parkinson's Disease-Associated Mutant α-Synuclein in Human and Transgenic Mouse Brain

  2000cited by this paper
• Neuropathology in Mice Expressing Human α-Synuclein

  2000cited by this paper
• Strong, Long-Term Transgene Expression in Rat Liver Using Chicken β-Actin Promoter Associated with Cytomegalovirus Immediate-Early Enhancer (CAG Promoter)

  2000cited by this paper
• Neuropathology in mice expressing human alpha-synuclein.

  2000cited by this paper
• Dopaminergic loss and inclusion body formation in alpha-synuclein mice: implications for neurodegenerative disorders.

  2000cited by this paper
• 4.5 kb of the rat tyrosine hydroxylase 5' flanking sequence directs tissue specific expression during development and contains consensus sites for multiple transcription factors.

  1999cited by this paper
• Increased susceptibility to sporadic Parkinson's disease by a certain combined α‐synuclein/apolipoprotein E genotype

  1999cited by this paper
• Expression of the prion protein in the rat forebrain--an immunohistochemical study.

  1999cited by this paper
• AlaSOPro mutation in the gene encoding α-synuclein in Parkinson's disease

  1998cited by this paper
• The synucleins: a family of proteins involved in synaptic function, plasticity, neurodegeneration and disease.

  1998cited by this paper
• Ala30Pro mutation in the gene encoding alpha-synuclein in Parkinson's disease.

  1998cited by this paper
• Mutation in the α-Synuclein Gene Identified in Families with Parkinson's Disease

  1997cited by this paper
• Isoform Specificity in the Relationship of Actin to Dendritic Spines

  1997cited by this paper
• Mutation in the alpha-synuclein gene identified in families with Parkinson's disease.

  1997cited by this paper
• Alpha-synuclein in Lewy bodies.

  1997cited by this paper
• NACP, a presynaptic protein, immunoreactivity in Lewy bodies in Parkinson's disease.

  1997cited by this paper
• α-Synuclein in Lewy bodies

  1997cited by this paper
• A vector for expressing foreign genes in the brains and hearts of transgenic mice.

  1996cited by this paper
• Early ontogeny of catecholaminergic cell lineage in brain and peripheral neurons monitored by tyrosine hydroxylase-lacZ transgene.

  1996cited by this paper
• Single-copy transgenic mice with chosen-site integration.

  1996cited by this paper
• Expression of APP in transgenic mice: a comparison of neuron-specific promoters.

  1996cited by this paper
• Mapping of a Gene for Parkinson's Disease to Chromosome 4q21-q23

  1996cited by this paper
• The precursor protein of non-Aβ component of Alzheimer's disease amyloid is a presynaptic protein of the central nervous system

  1995cited by this paper
• Developmental expression of the prion protein gene in glial cells.

  1995cited by this paper
• Overexpression of the rat inducible 70-kD heat stress protein in a transgenic mouse increases the resistance of the heart to ischemic injury.

  1995cited by this paper
• 5' upstream DNA sequence of the rat tyrosine hydroxylase gene directs high-level and tissue-specific expression to catecholaminergic neurons in the central nervous system of transgenic mice.

  1994cited by this paper
• DNA regulatory sequences of the rat tyrosine hydroxylase gene direct correct catecholaminergic cell-type specificity of a human growth hormone reporter in the CNS of transgenic mice causing a dwarf phenotype.

  1994cited by this paper
• The prion protein gene: a role in mouse embryogenesis?

  1992cited by this paper
• Synuclein: a neuron-specific protein localized to the nucleus and presynaptic nerve terminal

  1988cited by this paper
• A simple, versatile, sensitive and volume-independent method for quantitative protein determination which is independent of other external influences.

  1979cited by this paper

• Alpha-Synuclein Dynamics in Cerebral Ischemia

  2026cites this paper
• Cerebellar contributions to tau-mediated cognitive and behavioral dysfunction

  2025cites this paper
• Studying the Role of Myenteric Amyloidosis in Gastrointestinal Dysmotility and Enteric Neural Dysfunction Using APP/PS1 Mice—Is It an Adequate Animal Model?

  2025cites this paper
• α-Synuclein oligomers potentiate neuroinflammatory NF-κB activity and induce Cav3.2 calcium signaling in astrocytes

  2024cites this paper
• In Pancreatic Adenocarcinoma Alpha-Synuclein Increases and Marks Peri-Neural Infiltration

  2022cites this paper
• 5xFAD mice do not have myenteric amyloidosis, dysregulation of neuromuscular transmission or gastrointestinal dysmotility

  2022cites this paper
• Transgenic Mice Expressing Human α-Synuclein in Noradrenergic Neurons Develop Locus Coeruleus Pathology and Nonmotor Features of Parkinson's Disease

  2020cites this paper
• Transgenic Mice Expressing Human a -Synuclein in Noradrenergic Neurons Develop Locus Ceruleus Pathology and Nonmotor Features of Parkinson ’ s Disease

  2020cites this paper
• On the Role of Platelet-Generated Amyloid Beta Peptides in Certain Amyloidosis Health Complications

  2020cites this paper
• Neuropathological changes and cognitive deficits in rats transgenic for human mutant tau recapitulate human tauopathy

  2019cites this paper
• Transgenic mice expressing human alpha-synuclein in noradrenergic neurons develop locus coeruleus pathology and non-motor features of Parkinson’s disease

  2019cites this paper
• Clioquinol Improves Cognitive, Motor Function, and Microanatomy of the Alpha-Synuclein hA53T Transgenic Mice.

  2016cites this paper
• Alzheimer's disease mouse models based on presenilin-2 N141I: an in vivo study of spontaneous electrical activity by means of hippocampal extracellular recordings

  2016cites this paper
• Rodent Models of Autosomal Dominant Parkinson Disease

  2015cites this paper
• The metabolomics of alpha-synuclein (SNCA) gene deletion and mutation in mouse brain

  2014cites this paper
• Current Gaps in the Understanding of the Subcellular Distribution of Exogenous and Endogenous Protein TorsinA

  2014cites this paper
• Olfaction in Three Genetic and Two MPTP-Induced Parkinson’s Disease Mouse Models

  2013cites this paper
• Alpha-synuclein transgenic mice display age-related slowing of gastrointestinal motility associated with transgene expression in the vagal system.

  2012cites this paper
• Genetically engineered mouse models of Parkinson's disease.

  2012cites this paper
• Autonomic dysfunction and plasticity in micturition reflexes in human α‐synuclein mice

  2012influential citation
• OtpR regulated the growth, cell morphology of B. melitensis and tolerance to β-lactam agents.

  2012influential citation
• Parkinson’s disease mouse models in translational research

  2011influential citation
• Chronic exposure to manganese decreases striatal dopamine turnover in human alpha-synuclein transgenic mice.

  2011cites this paper
• Genetic mouse models for Parkinson's disease display severe pathology in glial cell mitochondria.

  2011cites this paper
• Gamma-synucleinopathy in mice (and humans?)

  2011cites this paper
• Genetic mouse models of Parkinson's disease The state of the art.

  2010cites this paper
• Spinal Cord Pathology in Alpha-Synuclein Transgenic Mice

  2010cites this paper
• Targeting the Progression of Parkinson’s Disease

  2009cites this paper
• Adult neural precursor cells unaffected in animal models of DYT1 dystonia

  2009cites this paper
• Changes in adult olfactory bulb neurogenesis in mice expressing the A30P mutant form of alpha‐synuclein

  2009cites this paper
• alpha-Synucleinopathy models and human neuropathology: similarities and differences.

  2008cites this paper
• Modeling synucleinopathies in genetically modified animals: Successes and failures

  2008cites this paper
• Transgenic Mice Overexpressing Tyrosine-to-Cysteine Mutant Human α-Synuclein

  2008cites this paper
• NeurodegenerationandMotorDysfunctioninaConditional ModelofParkinson'sDisease

  2008cites this paper
• Expression patterns of Doppel gene in golden hamster: quantification using real-time RT-PCR.

  2008cites this paper
• Untersuchung des Expressionsmusters und der Neuropathologie konditionaler Mausmodelle des Morbus Parkinson

  2008cites this paper
• Neurodegeneration and Motor Dysfunction in a Conditional Model of Parkinson's Disease

  2008cites this paper
• Modulation of α-synuclein expression in transgenic animals for modelling synucleinopathies — is the juice worth the squeeze?

  2008cites this paper
• Generation of a transgenic zebrafish model of Tauopathy using a novel promoter element derived from the zebrafish eno2 gene

  2007cites this paper
• Literature-Related Discovery (LRD)

  2007cites this paper
• Mono- and double-mutant mouse models of Parkinson's disease display severe mitochondrial damage.

  2007cites this paper
• α-Synucleinopathy models and human neuropathology: similarities and differences

  2007cites this paper
• The doppel gene biology: a scientific journey from brain to testis, and return

  2006cites this paper
• Sgk1, a cell survival response in neurodegenerative diseases.

  2005cites this paper
• Transgenic Mice Expressing Human a -Synuclein in Noradrenergic Neurons Develop Locus Coeruleus Pathology and Nonmotor Features of Parkinson ’ s Disease

  year unknowncites this paper